68Ga-PSMA在胃癌脑转移中的摄取
一名69岁有胃腺癌和前列腺腺癌病史的男性因前列腺癌生化复发接受68Ga-PSMA PET/CT再分期,显像示原发前列腺病灶、淋巴结、骨转移灶及脑病灶均有示踪剂摄取,脑病灶活检证实为胃癌转移。本病例提示68Ga-PSMA在前列腺及非前列腺转移灶中摄取谱多变,在合并恶性肿瘤患者PET/CT判读中存在潜在陷阱。
要点
- 68Ga-PSMA PET/CT在前列腺癌再分期中可意外显示非前列腺来源转移灶的摄取。
- 胃癌脑转移灶可表现为68Ga-PSMA摄取,活检证实为胃癌转移。
- 合并多种恶性肿瘤时,68Ga-PSMA PET/CT图像判读需警惕潜在陷阱。
核心结论
- 本病例提示68Ga-PSMA在前列腺及非前列腺转移灶中摄取谱多变,合并恶性肿瘤患者PET/CT判读存在潜在陷阱。
研究设计与样本
- 个案报道:1例69岁有胃腺癌和前列腺腺癌病史的男性,因前列腺癌生化复发行68Ga-PSMA PET/CT再分期。
主要发现
- 68Ga-PSMA PET/CT示原发前列腺病灶、淋巴结、骨转移灶及脑病灶均有示踪剂摄取。
- 脑病灶活检证实为胃癌转移。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 69-year-old man with a known history of gastric and prostate adenocarcinoma was referred to 68Ga-prostate-specific membrane antigen (PSMA) PET/CT for restaging due to biochemical recurrence of prostate cancer. 68Ga-PSMA PET/CT revealed tracer accumulation in the primary prostatic lesion, lymph node, bone metastases, and brain lesion, which was later confirmed on biopsy to be metastasis of gastric carcinoma. This case reminds us of the variable spectrum of 68Ga-PSMA uptake in prostatic and nonprostatic metastatic lesions, the potential pitfalls on PET/CT images in the workup of patients with concomitant malignancies.
引用
- Kesim S, Oksuzoglu K. 68Ga-PSMA Uptake in Brain Metastasis of Gastric Carcinoma. Clin Nucl Med. 2022. PMID: 35930713. doi:10.1097/RLU.0000000000004199
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。